Insiders who reported open-market trades in the last 12 months at the companies Cedric Francois files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
A. Sinclair Dunlop - $738K in APLS purchases and sales in the last 12 months
David O. Watson - $697K in APLS purchases and sales in the last 12 months
Cedric Francois is a corporate insider, tracked as Chief Executive Officer of Apellis Pharmaceuticals, Inc. (APLS). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Cedric Francois last file a Form 4?
The most recent primary Form 4 on record is dated 14 May 2026, one of 11 filings going back to 2024.
Has Cedric Francois been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($10.54M) across all tracked filings.
Cedric Francois is Chief Executive Officer of Apellis Pharmaceuticals, Inc. (APLS). 11 SEC Form 4 filings on record going back to 2024, most recently on 14 May 2026. Lifetime open-market sales: $10.54M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Cedric Francois.
InsiderAlpha's records for Cedric Francois go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
